Phase 3 study finds inebilizumab effective for immunoglobulin G4–related disease

  • Post author:
  • Post category:uncategorized

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.